Skip to main content
63°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Health care industry
Companies
Health & Science
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
U/S/ Markets
Zealand Pharma A/S
NVIDIA Corp
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
Hospitals
Mobile
Technology
From
CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
May 24, 2024
Tags
Biotechnology
Business
Business News
From
CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
May 23, 2024
Tags
S&P 500
Business
Sigma Lithium Corp
From
CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
Tags
Investment strategy
Bristol/Myers Squibb Co
Pharmaceuticals
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Health & Science
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags
Carmot Therapeutics Inc
Novo Nordisk A/S
Biotechnology
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Biotech and Pharmaceuticals
Healthy Returns
Social issues
From
CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags
Health care industry
Health & Science
Companies
From
CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
May 13, 2024
Tags
Technology
Alphabet Inc
Microsoft Corp
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Health & Science
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
Science
Novo Nordisk A/S
Biotechnology
From
CNBC.com News
Within a few years, generative AI will be designing new drugs all on its own
May 05, 2024
Tags
Drugs
Eli Lilly and Co
Artificial intelligence
From
CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
May 03, 2024
Tags
Companies
Health & Science
Health care industry
From
CNBC.com News
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
May 03, 2024
Tags
Pharmaceuticals
LVMH Moet Hennessy Louis Vuitton SE
Europe News
From
CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
May 02, 2024
Tags
Biotech and Pharmaceuticals
Breaking news
Earnings
From
CNBC.com News
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
April 30, 2024
Tags
Health care industry
Health & Science
Companies
From
CNBC.com News
5 things to know before the stock market opens Monday
April 29, 2024
Tags
Charter Communications Inc
Peloton Interactive Inc
Berkshire Hathaway Inc
From
CNBC.com News
Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly
April 26, 2024
Tags
Starbucks Corp
Amazon/com Inc
Business News
From
CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
April 20, 2024
Tags
Constellation Brands Inc
Jack in the Box Inc
Portillos Inc
From
CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
April 17, 2024
Tags
Health & Science
Companies
Health care industry
From
CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
April 17, 2024
Tags
Biotech and Pharmaceuticals
Breaking news
Business
From
CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
April 12, 2024
Tags
Breaking news
Social issues
Biotech and Pharmaceuticals
From
CNBC.com News
Cramer says stocks that pulled back Tuesday still 'have everything going for them'
April 09, 2024
Tags
Mad Money
U/S/ Markets
Stock markets
From
CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
April 04, 2024
Tags
Biotech and Pharmaceuticals
Business News
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
April 03, 2024
Tags
Biotech and Pharmaceuticals
Healthy Returns
Eli Lilly and Co
From
CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
March 27, 2024
Tags
Companies
Health & Science
Health care industry
From
CNBC.com News
Cramer says the market is broadening beyond the mega caps, reviews the S&P 500's hottest stocks
March 26, 2024
Tags
Deckers Outdoor Corp
stocks
Markets
From
CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
March 26, 2024
Tags
Viking Therapeutics Inc
Biotech and Pharmaceuticals
Breaking news
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.